Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Pegfilgrastim Atc Code According To Who L03Aa13

Deadline: 30 Apr 2026

Germany

Ref. No.: 5975224

EMD:Ref Document

Bid Value: Ref Document

352 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage Form Lse

Deadline: 10 May 2026

Germany

Ref. No.: 5968352

EMD:Ref Document

Bid Value: Ref Document

362 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acarbose Not In Standard Size 2

Deadline: 10 May 2026

Germany

Ref. No.: 5965414

EMD:Ref Document

Bid Value: Ref Document

362 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine As An Otc Medicinal Product

Deadline: 10 May 2026

Germany

Ref. No.: 5965319

EMD:Ref Document

Bid Value: Ref Document

362 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V On Active Ingredients Medicines Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5901848

EMD:Ref Document

Bid Value: Ref Document

362 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Combination Dolutegravir I Rilpivirine Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864985

EMD:Ref Document

Bid Value: Ref Document

362 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Fosamprenavir Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864945

EMD:Ref Document

Bid Value: Ref Document

362 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegvisomant Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864924

EMD:Ref Document

Bid Value: Ref Document

362 Days Left

Framework For Clinical Trial Participants Data Reutilization For A Fully Transparent And Ethical Ecosystem

Deadline: 31 Dec 2025

Italy

Ref. No.: 5862823

EMD:Ref Document

Bid Value: Ref Document

232 Days Left

Saturated Bioisosteres Of Benzene And Their Application In Drug Design

Deadline: 31 Mar 2026

Ukraine

Ref. No.: 5845871

EMD:Ref Document

Bid Value: Ref Document

322 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Leuprorelin Without Pli

Deadline: 10 Nov 2025

Germany

Ref. No.: 5808710

EMD:Ref Document

Bid Value: Ref Document

181 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Fondaparinux

Deadline: 10 Nov 2025

Germany

Ref. No.: 5808612

EMD:Ref Document

Bid Value: Ref Document

181 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Flupentixol

Deadline: 10 Nov 2025

Germany

Ref. No.: 5806518

EMD:Ref Document

Bid Value: Ref Document

181 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Dexketoprofen

Deadline: 10 Nov 2025

Germany

Ref. No.: 5806329

EMD:Ref Document

Bid Value: Ref Document

181 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ramipril Amlodipine Hct

Deadline: 10 Nov 2025

Germany

Ref. No.: 5803773

EMD:Ref Document

Bid Value: Ref Document

181 Days Left

Showing 48961 to 48975 of 49127 results

‹
1
2
...
3262
3263
3264
3265
3266
3267
3268
...
3275
3276
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!